November 18, 2019. We therefore respectfully urge the FDA to revise the proposed guidance in ways that ensure that all medical devices undergo more rigorous testing prior to being approved or cleared.
Read More »On Health Policy
Dr. Diana Zuckerman’s Statement on FDA’s Draft Guidance on Labeling for Breast Implants
October 23, 2019. The FDA’s draft includes the types of information that we have proposed to the FDA in recent months in our work with patient advocates and plastic surgeons. The devil is in the details, so we look forward to working with the FDA to finalize these materials so that patients can make better informed decisions in the future than most women considering breast implants have been able to make.
Read More »NCHR Letter to Mayor Cohn and Members of the Rye City Council Concerning Artificial Turf and Playgrounds
October 16, 2019. We have been contacted by families in Rye who are concerned about the risks of artificial turf and playgrounds. We agree with them that converting grass fields to artificial turf poses unnecessary dangers to children in your community.
Read More »Coalition Letter to Congress Supporting Reauthorization of Patient-Centered Outcomes Research Institute (PCORI)
September 10, 2019. As members of the Patient, Consumer, and Public Health Coalition, we are writing to express our strong support for the reauthorization of the Patient-Centered Outcomes Research Institute (PCORI).
Read More »NCHR Letter to Congress Supporting Reauthorization of Patient-Centered Outcomes Research Institute (PCORI)
September 12, 2019. If the United States is to regain the stature of offering a top-notch healthcare system that is the model for other countries and make the most of our considerable investment in personalized and precision medicine, PCORI must be sustained.
Read More »